Ozturk, V. Et Al. 2013. Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial. PAIN PRACTICE , vol.13, no.3 , 191-197.

Ozturk, V., ERTAS, M., Baykan, B., ŞİRİN, H., & Ozge, A., (2013). Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial. PAIN PRACTICE , vol.13, no.3, 191-197.

Ozturk, Vesile Et Al. "Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial," PAIN PRACTICE , vol.13, no.3, 191-197, 2013

Ozturk, Vesile Et Al. "Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial." PAIN PRACTICE , vol.13, no.3, pp.191-197, 2013

Ozturk, V. Et Al. (2013) . "Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial." PAIN PRACTICE , vol.13, no.3, pp.191-197.

@article{article, author={Vesile Ozturk Et Al. }, title={Efficacy and Safety of 400 and 800mg Etodolac vs. 1,000mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial}, journal={PAIN PRACTICE}, year=2013, pages={191-197} }